ASHP therapeutic position statement on the appropriate use of medications in the treatment of attention-deficit/hyperactivity disorder in pediatric patients.
Dopheide
Julie A
JA
Schools of Pharmacy and Medicine, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90089, USA. dopheide@usc.edu
D000328:Adult; D019969:Amphetamine-Related Disorders / Q000209:etiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D016903:Drug Monitoring; D006801:Humans; D017410:Practice Guidelines as Topic; D012957:Societies, Pharmaceutical
D000697:Central Nervous System Stimulants